Literature DB >> 6407418

Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever.

L G Kaplowitz, J V Lange, J J Fischer, D H Walker.   

Abstract

Blood rickettsial titers, skin biopsy results, and circulating endotoxin measurements were correlated with the clinical course of disease in patients with Rocky Mountain spotted fever (RMSF). Nine of 11 patients with documented RMSF had Rickettsia rickettsii isolated from plasma samples. Of the eight patients in whom rickettsial titers were measured, seven had 10(0.7) to 10(1.2) median tissue culture infective doses (TCID50) per milliliter; all seven had mild to moderately severe disease. One patient with fulminant, fatal untreated RMSF had 10(3) TCID50/mL of postmortem plasma. Two patients from whom rickettsiae were not isolated had positive direct immunofluorescent stains of skin biopsy material for R rickettsii. Circulating endotoxin was present in two patients, one with documented rickettsemia and one with a positive skin biopsy alone. Only low levels of circulating rickettsiae are present in patients with moderately severe disease. Measurement of plasma endotoxin is not useful in the early diagnosis of RMSF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407418

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

Review 1.  Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

2.  Optimization and Evaluation of a Multiplex Quantitative PCR Assay for Detection of Nucleic Acids in Human Blood Samples from Patients with Spotted Fever Rickettsiosis, Typhus Rickettsiosis, Scrub Typhus, Monocytic Ehrlichiosis, and Granulocytic Anaplasmosis.

Authors:  Megan E Reller; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  Rocky Mountain spotted fever: a disease in need of microbiological concern.

Authors:  D H Walker
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  Probe directed at a segment of Rickettsia rickettsii rRNA amplified with polymerase chain reaction.

Authors:  K H Wilson; R Blitchington; P Shah; G McDonald; R D Gilmore; L P Mallavia
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

6.  Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology.

Authors:  T Tzianabos; B E Anderson; J E McDade
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

Review 7.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Molecular Investigations of Rickettsia helvetica infection in dogs, foxes, humans, and Ixodes ticks.

Authors:  Felicitas S Boretti; Andrea Perreten; Marina L Meli; Valentino Cattori; Barbara Willi; Nicole Wengi; Sándor Hornok; Hanspeter Honegger; Daniel Hegglin; Roman Woelfel; Claudia E Reusch; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Appl Environ Microbiol       Date:  2009-03-27       Impact factor: 4.792

9.  Effect of antibody on the rickettsia-host cell interaction.

Authors:  Hui-Min Feng; Ted Whitworth; Vsevolod Popov; David H Walker
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Production and characterization of monoclonal antibodies to Rickettsia rickettsii.

Authors:  J V Lange; D H Walker
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.